The<unk>  occurs in 1 child in every 15,000 to 20,000 births. More than 90% of the cases are associated with autoimmune disease and transference of maternal autoantibodies. Without considering the gender, the age of diagnosis or the associated diseases, mortality rate is around 20%. The majority of<unk> -related deaths occur in the first 3 months after birth followed by fetal death, and it is less common to occur after the third month of age. Mortality rate is very high when the disease is diagnosed prenatally, and declines dramatically with older diagnosis ages. Around 60% - 70% of the patients will need pace-maker implantation regardless of the age of diagnosis. The disease seems to affect both males and females equally. The survival rate is heavily affected by the associated diseases, and it is higher in autoimmune-mediated<unk>  patients compared to<unk>  patients with<unk>  cardiac structural problems. Recurrence rate: mothers who had pregnancies associated with<unk> , have a 16 - 18% chance of having kids with heart<unk>  in the following pregnancy. A study in the United States showed that the vast majority of the affected mothers are of a Caucasian ethnicity, despite the fact that Systemic Lupus Erythematosus (SLE) is more common among minorities. +Table. I: The recurrence rate for pregnancies following the<unk> -affected births Outcome Percentage of Pregnancies Healthy 73%<unk>  16% Fetal Demise 2% Neonatal Death 2%
Congenital heart block
Ectopic pacemaker
Cyanotic heart defect
Acyanotic heart defect
Cardiac myxoma
Heart valve dysplasia
Primary tumors of the heart
Broken Heart